Previous close | 13.97 |
Open | 14.47 |
Bid | 14.85 x 400 |
Ask | 14.92 x 400 |
Day's range | 14.10 - 15.21 |
52-week range | 4.94 - 20.52 |
Volume | |
Avg. volume | 1,700,304 |
Market cap | 716.829M |
Beta (5Y monthly) | 1.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cardlytics Inc (NASDAQ:CDLX), a company specializing in advertising platforms that leverage purchase intelligence to make marketing more relevant and measurable, has reported an insider sale according to a recent SEC filing.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cardlytics fair value estimate is US$19.74 Current share price...
On April 1, 2024, CEO Karim Temsamani of Cardlytics Inc (NASDAQ:CDLX), a company specializing in purchase intelligence to make marketing more relevant and measurable, sold 32,718 shares of the company.